US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avidity Biosciences, Inc.

28.90

+2.248.40%

Volume:856.30K

Turnover:24.30M

Market Cap:3.47B

PE:-10.01

High:29.36

Open:26.26

Low:26.01

Close:26.66

Loading ...

Overview Company News Filings

Hoth Therapeutics Announces Granted Japanese Patent for Novel RNA-Based Cancer Therapy Targeting KIT Gene - Expands Global IP in Precision Oncology Platform

ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth

Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9

Circio Enters Research Agreement with Lonza to Advance RNA Technology

Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for the STARR® mRNA Vaccine Candidate ARCT-2304 for Pandemic Influenza A Virus H5N1

Avidity Biosciences Price Target Maintained With a $60.00/Share by Needham

Avidity Says Japan Grants Orphan Drug Status to Del-Desiran for Myotonic Dystrophy Type 1

MT Newswires Live

BRIEF-Avidity Biosciences Receives Orphan Drug Designation In Japan For Delpacibart Etedesiran

Avidity Biosciences Receives Orphan Drug Designation in Japan for Delpacibart Etedesiran (Del-Desiran) for Treatment of Myotonic Dystrophy Type 1

THOMSON REUTERS

Avidity Biosciences Inc - Expects to Complete Phase 3 Harbor Study Enrollment in Mid-2025

THOMSON REUTERS

Avidity Biosciences Receives Orphan Drug Designation in Japan for Delpacibart Etedesiran (del-desiran) for Treatment of Myotonic Dystrophy Type 1

Avidity Biosciences (RNA): Among Unstoppable Stocks That Could Double Your Money

Avidity Biosciences (RNA) Soars 11.3%: Is Further Upside Left in the Stock?

Avidity Biosciences’ Promising Progress in FORTITUDE Study Boosts Buy Rating

Biotech stocks slide as Marks resignation seen being negative for sector

Avidity Biosciences to Participate in Upcoming Investor Conference

Avidity Completes Enrollment in Del-brax Trial's Biomarker Group for Facioscapulohumeral Muscular Dystrophy

MT Newswires Live

Avidity Biosciences Inc: Regulatory Alignment on Global Phase 3 Del-Brax Trial Design and Study Initiation Anticipated in Q2 2025

THOMSON REUTERS

Avidity Biosciences Inc: Plan to Present Topline Data From Fortitude Dose Escalation Cohorts in Q2 2025

THOMSON REUTERS

Avidity Biosciences Completes Enrollment in Biomarker Cohort in Phase 1/2 Fortitude™ Trial for Delpacibart Braxlosiran (Del-Brax) in People Living With Facioscapulohumeral Muscular Dystrophy

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/RNA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNA\",,,,,undefined,":{"symbol":"RNA","market":"US","secType":"STK","nameCN":"Avidity Biosciences, Inc.","latestPrice":28.9,"timestamp":1745263238200,"preClose":26.66,"halted":0,"volume":856303,"delay":0,"floatShares":92698253,"shares":120212301,"eps":-2.888476,"marketStatus":"Trading","change":2.24,"latestTime":"04-21 15:20:58 EDT","open":26.26,"high":29.36,"low":26.0118,"amount":24299240.870457,"amplitude":0.125589,"askPrice":28.95,"askSize":164,"bidPrice":28.87,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.888476,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745265600000},"marketStatusCode":2,"adr":0,"listingDate":1591934400000,"exchange":"NASDAQ","adjPreClose":26.66,"preHourTrading":{"tag":"盘前","latestPrice":26,"preClose":26.66,"latestTime":"06:34 EDT","volume":251,"amount":6566.620585,"timestamp":1745231656695},"postHourTrading":{"tag":"盘后","latestPrice":26.66,"preClose":26.66,"latestTime":"17:37 EDT","volume":25784,"amount":687401.44,"timestamp":1744925858900},"volumeRatio":0.620254,"impliedVol":0.8925,"impliedVolPercentile":0.896},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNA\",,,,,undefined,":{"symbol":"RNA","floatShares":92698253,"roa":"-21.60%","roe":"-33.47%","lyrEps":-2.888476,"volumeRatio":0.620254,"shares":120212301,"dividePrice":0,"high":29.36,"amplitude":0.125589,"preClose":26.66,"low":26.0118,"week52Low":21.51,"pbRate":"2.44","psRate":"318.82","week52High":56,"institutionHeld":0,"latestPrice":28.9,"committee":-0.242424,"eps":-2.888476,"divideRate":0,"volume":856303,"delay":0,"ttmEps":-2.888476,"open":26.26,"prevYearClose":29.08,"prevWeekClose":26.66,"prevMonthClose":29.52,"prevQuarterClose":29.52,"fiveDayClose":25.58,"twentyDayClose":30.84,"sixtyDayClose":30.13},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RNA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528717312","title":"Hoth Therapeutics Announces Granted Japanese Patent for Novel RNA-Based Cancer Therapy Targeting KIT Gene - Expands Global IP in Precision Oncology Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2528717312","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528717312?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:01","pubTimestamp":1744891260,"startTime":"0","endTime":"0","summary":"Patent Grant Strengthens Hoth's RNA Therapeutics Pipeline with Broad Claims Covering KIT-Targeted Antisense Oligomers for Oncology and Immunology Applications. NEW YORK, April 17, 2025 /PRNewswire/ --Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company developing next-generation RNA-targeted precision therapies, today announced it has been granted a key patent by the Japan Patent Office , expanding its global intellectual property portfolio in RNA-based cancer therapeutics.The newly issued patent secures broad claims covering antisense oligomers that target theKITgene — a clinically validated oncogene associated with gastrointestinal stromal tumors , leukemia, mastocytosis, and other cancers. These oligomers are designed to alter pre-mRNA splicing or reduce KIT protein expression, offering a highly targeted therapeutic mechanism.\"This patent significantly strengthens Hoth's position in the RNA therapeutics space and marks a major milestone in our global strategy,\"saidRob","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/hoth-therapeutics-announces-granted-japanese-120100720.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hoth-therapeutics-announces-granted-japanese-120100720.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HOTH","LU1481599808.USD","IE00B3T34201.USD","BK4505","BK4585","LU1487256676.USD","LU1169589451.USD","BK4588","LU1169590202.USD","LU2463526074.USD","BK4136","IP","RNA","BK4007","LU1481600234.SGD","BK4139"],"gpt_icon":0},{"id":"2527954158","title":"ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2527954158","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527954158?lang=en_us&edition=fundamental","pubTime":"2025-04-14 19:00","pubTimestamp":1744628400,"startTime":"0","endTime":"0","summary":"LEIDEN, Netherlands & CAMBRIDGE, Mass., April 14, 2025  -- ProQR Therapeutics NV.  , a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer RNA editing technology platform, today announced the appointment of Dennis Hom as Chief Financial Officer  and Cristina Lopez Lopez, MD, PhD, as Chief Medical Officer . These key leadership appointments support the advancement of the Company’s Axiomer platform technology and pipeline of RNA editing programs as it enters the clinical stage.“We are thrilled to welcome Dennis and Cristina to ProQR at such an important time in our evolution,” said Daniel A. de Boer, Founder and Chief Executive Officer of ProQR. “Dennis brings deep expertise in corporate finance and business development strategy, while Cristina brings extensive experience in translational science, clinical development, and regulatory affairs. Their combined leadership capabilities will be instrumental as we advance our Axiomer platfor","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/proqr-strengthens-leadership-appointments-cfo-110000986.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4523","LU2229751404.USD","LU2092937221.SGD","CFO","RNA","LU2413666426.HKD","IE00BN0W2T93.GBP","LU0347712357.USD","G","A","BK4121","BK4106","BK4505","BK4588","IE00BN0W2V16.EUR","LU1165135440.EUR","LU2041044095.USD","LU1543694498.USD","BK4585","IE00BN0W2W23.USD","LU2413666699.HKD","PRQR","LU1166156734.SGD","LU2089279066.USD","LU1721428933.USD","BK4226","LU0702159699.USD","LU0702159343.USD","BK4567"],"gpt_icon":0},{"id":"2527533581","title":"Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9","url":"https://stock-news.laohu8.com/highlight/detail?id=2527533581","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527533581?lang=en_us&edition=fundamental","pubTime":"2025-04-14 19:00","pubTimestamp":1744628400,"startTime":"0","endTime":"0","summary":"Single infusion of VERVE-102 led to dose-dependent decreases in blood PCSK9 and LDL-C, with mean reduction in LDL-C of 53% and a maximum reduction of 69% observed in the 0.6 mg/kg dose cohort VERVE-10","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/14/3060774/0/en/Verve-Therapeutics-Announces-Positive-Initial-Data-from-the-Heart-2-Phase-1b-Clinical-Trial-of-VERVE-102-an-In-Vivo-Base-Editing-Medicine-Targeting-PCSK9.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNA","ALT","PD","BK4588","LU1169589451.USD","BK4139","LU1878469433.USD","LU1169590202.USD","BK4023","BK4539","BK4585","BK4599","BK4505","VERV"],"gpt_icon":0},{"id":"2526507782","title":"Circio Enters Research Agreement with Lonza to Advance RNA Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2526507782","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526507782?lang=en_us&edition=fundamental","pubTime":"2025-04-11 13:34","pubTimestamp":1744349674,"startTime":"0","endTime":"0","summary":"Targovax ASA ( ($GB:0RIS) ) has provided an update. Circio Holding ASA’s subsidiary, Circio AB, has entered a research evaluation agreement with Lo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/circio-enters-research-agreement-with-lonza-to-advance-rna-technology?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/circio-enters-research-agreement-with-lonza-to-advance-rna-technology?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","BK4585","BK4588","BK4139","RNA"],"gpt_icon":0},{"id":"2526563875","title":"Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for the STARR® mRNA Vaccine Candidate ARCT-2304 for Pandemic Influenza A Virus H5N1","url":"https://stock-news.laohu8.com/highlight/detail?id=2526563875","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526563875?lang=en_us&edition=fundamental","pubTime":"2025-04-10 20:00","pubTimestamp":1744286400,"startTime":"0","endTime":"0","summary":"SAN DIEGO, April 10, 2025----Arcturus Therapeutics Holdings Inc. , a commercial messenger RNA medicine company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced that the U.S. Food and Drug Administration  has granted Fast Track Designation for the self-amplifying mRNA  vaccine candidate, ARCT-2304, designed for active immunization to protect against disease caused by influenza A H5N1 subtype contained in the vaccine. This designation recognizes the potential of ARCT-2304 as an innovative approach to address unmet medical needs for the prevention of disease caused by pandemic influenza A virus H5N1, a significant global health risk. The Phase 1 clinical study initiated in November 2024.\"We are pleased to receive Fast Track Designation from the FDA for ARCT-2304,\" said Joseph Payne, President and CEO of Arcturus Therapeutics. \"We remain steadfast in our commitment to the U.S. government to develop safe ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arcturus-therapeutics-receives-u-fda-120000445.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4141","IE00B5TLWC47.USD","BK4093","BK4139","BK4505","BK4567","NA","FAST","ARCT","BK4104","IE00BYQQ9H92.USD","CF","RNA","IE00BFXG0V08.USD","BK4588"],"gpt_icon":0},{"id":"2526369858","title":"Avidity Biosciences Price Target Maintained With a $60.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2526369858","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526369858?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:51","pubTimestamp":1744203060,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RNA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 09, 2025 08:51 ET (12:51 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNA"],"gpt_icon":0},{"id":"2525900428","title":"Avidity Says Japan Grants Orphan Drug Status to Del-Desiran for Myotonic Dystrophy Type 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2525900428","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525900428?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:34","pubTimestamp":1744119278,"startTime":"0","endTime":"0","summary":"Avidity Biosciences  said Tuesday it has received orphan drug designation from Japan's Ministry of Health, Labor and Welfare for delpacibart etedesiran, or del-desiran, to potentially treat myotonic dystrophy type 1, a neuromuscular disease.The investigational drug has also received breakthrough therapy, orphan drug and fast track designations by the US Food and Drug Administration, and orphan designation by the European Medicines Agency, Avidity said.The company said it expects to complete enrollment in a phase 3 trial in the middle of this year and file marketing applications starting 2026 in the US, European Union and Japan.Avidity shares were rising more than 2% in early trading.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4588","BK4505","BK4139","RNA"],"gpt_icon":0},{"id":"2525970588","title":"BRIEF-Avidity Biosciences Receives Orphan Drug Designation In Japan For Delpacibart Etedesiran","url":"https://stock-news.laohu8.com/highlight/detail?id=2525970588","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525970588?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:19","pubTimestamp":1744118368,"startTime":"0","endTime":"0","summary":"BRIEF-Avidity Biosciences Receives Orphan Drug Designation In Japan For Delpacibart EtedesiranApril 8 (Reuters) - Avidity Biosciences Inc RNA.O:AVIDITY BIOSCIENCES RECEIVES ORPHAN DRUG DESIGNATION IN ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nTUAZCWGS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","BK4585","BK4588","RNA"],"gpt_icon":0},{"id":"2525892294","title":"Avidity Biosciences Receives Orphan Drug Designation in Japan for Delpacibart Etedesiran (Del-Desiran) for Treatment of Myotonic Dystrophy Type 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2525892294","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525892294?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:00","pubTimestamp":1744117220,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nTUAZCWGS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","RNA","BK4139","BK4585","BK4588"],"gpt_icon":0},{"id":"2525892211","title":"Avidity Biosciences Inc - Expects to Complete Phase 3 Harbor Study Enrollment in Mid-2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2525892211","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525892211?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:00","pubTimestamp":1744117220,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nTUAZCWGS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4585","BK4588","BK4139","RNA"],"gpt_icon":0},{"id":"2525881534","title":"Avidity Biosciences Receives Orphan Drug Designation in Japan for Delpacibart Etedesiran (del-desiran) for Treatment of Myotonic Dystrophy Type 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2525881534","media":"PR Newswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525881534?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:00","pubTimestamp":1744117200,"startTime":"0","endTime":"0","summary":"Del-desiran first-ever investigational treatment for DM1 to receive Orphan Drug designation in Japan. SAN DIEGO, April 8, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. , a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates , today announced that the Japan Ministry of Health, Labour and Welfare  has granted Orphan Drug designation  to delpacibart etedesiran  for the treatment of myotonic dystrophy type 1 , an investigational treatment designed to address the root cause of DM1, an underrecognized, progressive and often fatal neuromuscular disease with no approved therapies. Del-desiran is the first investigational treatment for DM1 to receive Orphan Drug designation in Japan. Del-desiran has also received Breakthrough Therapy, Orphan Drug and Fast Track designations by the U.S. Food and Drug Administration  and Orphan designation by the European Medicines Agency .About the Phase 3 HARBOR TrialThe global Phase 3 HA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/avidity-biosciences-receives-orphan-drug-130000338.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/avidity-biosciences-receives-orphan-drug-130000338.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4505","BK4183","BK4585","RNA","ODD","BK4588","BK4139"],"gpt_icon":0},{"id":"2525743686","title":"Avidity Biosciences (RNA): Among Unstoppable Stocks That Could Double Your Money","url":"https://stock-news.laohu8.com/highlight/detail?id=2525743686","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525743686?lang=en_us&edition=fundamental","pubTime":"2025-04-06 05:22","pubTimestamp":1743888128,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Unstoppable Stocks That Could Double Your Money. In this article, we are going to take a look at where Avidity Biosciences, Inc.  stands against other unstoppable stocks that could double your money.Fundstrat’s head of research, Tom Lee, stated to CNBC on March 31 that market conditions indicate oversold status and potential bottom formation regardless of ongoing downward trends. Investors maintain their focus on government policies and tariff situations, and their economic impact. According to his estimates, the April 2 tariff updates should also clarify the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/avidity-biosciences-rna-among-unstoppable-212208803.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QLD","SQQQ","USAW.SI","BK4139","RNA","TSYW.SI",".IXIC","QID","NQmain","NVIW.SI","BK4505","BK4585","MNQmain","PSQ","BK4588","TQQQ","USJW.SI"],"gpt_icon":1},{"id":"2524264456","title":"Avidity Biosciences (RNA) Soars 11.3%: Is Further Upside Left in the Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2524264456","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524264456?lang=en_us&edition=fundamental","pubTime":"2025-04-03 21:34","pubTimestamp":1743687240,"startTime":"0","endTime":"0","summary":"Avidity Biosciences, Inc.  shares soared 11.3% in the last trading session to close at $29.77. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 6.4% loss over the past four weeks.The sudden surge in the stock price can be attributed to the positive investor mindset regarding the company's distinguished rare diseases pipeline. Avidity is currently evaluating three investigational candidates in separate mid to late-stage clinical studies for three different muscle disease indications.For Avidity Biosciences, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on RNA going forward to see if this recent jump can turn into more strength down the road.Avidity Biosciences belongs to the Zacks Medical - Biomedical and Genetics industry. An","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/avidity-biosciences-rna-soars-11-133400061.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4505","MIRM","RNA","BK4588","BK4139"],"gpt_icon":0},{"id":"2524419488","title":"Avidity Biosciences’ Promising Progress in FORTITUDE Study Boosts Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2524419488","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524419488?lang=en_us&edition=fundamental","pubTime":"2025-04-03 00:16","pubTimestamp":1743610565,"startTime":"0","endTime":"0","summary":"Leerink Partners analyst Joseph Schwartz maintained a Buy rating on Avidity Biosciences (RNA – Research Report) on March 31 and set a price target ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/avidity-biosciences-promising-progress-in-fortitude-study-boosts-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/avidity-biosciences-promising-progress-in-fortitude-study-boosts-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS","RNA"],"gpt_icon":0},{"id":"2524491531","title":"Biotech stocks slide as Marks resignation seen being negative for sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2524491531","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524491531?lang=en_us&edition=fundamental","pubTime":"2025-04-01 23:50","pubTimestamp":1743522637,"startTime":"0","endTime":"0","summary":"Shares of several biotech and biopharma names are under pressure on Monday following the resignation of the head of the Food and Drug Administration’s Center for Biologics Evaluation and Research, Peter Marks. RBC Capital says the development is “not good for the biotech industry even beyond vaccines.” Voicing a similar opinion, BMO Capital told investors this morning that it sees the news as a “significant negative” for the biopharma and biotech sectors.Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks.“NOT GOOD” FOR BIOTECH SECTOR: RBC Capital believes the resignation of the head of the FDA’s Center for Biologics Evaluation and Research, Peter Marks, is “not good for the biotech industry even beyond vaccines.” Marks had been a key advocate for more flexible, efficient approval processes for drugs, particularly those for orphan diseases such as gene therapies, the firm tells investors in a research note.PRICE ACTION: In mornin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/biotech-stocks-slide-marks-resignation-155037694.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotech-stocks-slide-marks-resignation-155037694.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RGNX","TSHA","IE00B4R5TH58.HKD","NGNE","IE00B3T34201.USD","FDMT","GLPG","MGX","LEGN","PRME","CRSP","MGTX","SRPT","RCKTW","BK4568","REGN","BK4532","BK4578","VERV","LU0320765992.SGD","IE00BFTCPJ56.SGD","BK4551","PCRX","IE0002141913.USD","LU0417517546.SGD","LU1430594728.SGD","LU2362540622.SGD","VRTX","LU2468319806.SGD","LU1571399168.USD","DTIL","RNA","MRNA","IE0009355771.USD","LU2023250504.SGD","GILD","LU0823416689.USD","KPTI","BK4139","LU0058720904.USD","PTCT","IE00BZ9MQY76.HKD","BEAM","LU2462157665.USD","NTLA","LU1066053197.SGD","BK4007","DYN","LU1066051498.USD","LU1035775433.USD","LU1069344957.HKD","RCKT"],"gpt_icon":1},{"id":"2524111417","title":"Avidity Biosciences to Participate in Upcoming Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2524111417","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524111417?lang=en_us&edition=fundamental","pubTime":"2025-04-01 21:00","pubTimestamp":1743512400,"startTime":"0","endTime":"0","summary":"SAN DIEGO, April 1, 2025 /PRNewswire/ --Avidity Biosciences, Inc. , a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates , today announced that Avidity management will participate in a fireside chat during the following investor conference:. 24th Annual Needham Virtual Healthcare Conferenceon Tuesday, April 8, 2025, at 3:00 p.m. ET","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/avidity-biosciences-participate-upcoming-investor-130000698.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/avidity-biosciences-participate-upcoming-investor-130000698.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4588","RNA","BK4139","BK4505"],"gpt_icon":0},{"id":"2523925294","title":"Avidity Completes Enrollment in Del-brax Trial's Biomarker Group for Facioscapulohumeral Muscular Dystrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2523925294","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523925294?lang=en_us&edition=fundamental","pubTime":"2025-03-31 22:55","pubTimestamp":1743432938,"startTime":"0","endTime":"0","summary":"Avidity Biosciences (RNA) said Monday it completed enrollment in the biomarker group in a phase 1/2 trial of delpacibart braxlosiran, or del-brax, in people with facioscapulohumeral muscular dystrophy","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4505","BK4139","RNA","BK4588"],"gpt_icon":0},{"id":"2523941279","title":"Avidity Biosciences Inc: Regulatory Alignment on Global Phase 3 Del-Brax Trial Design and Study Initiation Anticipated in Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2523941279","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523941279?lang=en_us&edition=fundamental","pubTime":"2025-03-31 21:01","pubTimestamp":1743426080,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE0Y2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RNA","BK4505","BK4585","BK4588"],"gpt_icon":0},{"id":"2523941274","title":"Avidity Biosciences Inc: Plan to Present Topline Data From Fortitude Dose Escalation Cohorts in Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2523941274","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523941274?lang=en_us&edition=fundamental","pubTime":"2025-03-31 21:01","pubTimestamp":1743426080,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE0Y2:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RNA","BK4505","BK4585","BK4588"],"gpt_icon":0},{"id":"2523941270","title":"Avidity Biosciences Completes Enrollment in Biomarker Cohort in Phase 1/2 Fortitude™ Trial for Delpacibart Braxlosiran (Del-Brax) in People Living With Facioscapulohumeral Muscular Dystrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2523941270","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523941270?lang=en_us&edition=fundamental","pubTime":"2025-03-31 21:01","pubTimestamp":1743426080,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE0Y2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RNA","BK4505","BK4585","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":197,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RNA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-27","symbol":"RNA","fiscalQuarterEnding":"2024/12","expectedEps":-0.84,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"post","actualEps":-0.8},{"market":"US","date":"2024-11-07","symbol":"RNA","fiscalQuarterEnding":"2024/09","expectedEps":-0.79,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.65},{"market":"US","date":"2024-08-09","symbol":"RNA","fiscalQuarterEnding":"2024/06","expectedEps":-0.76,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"post","actualEps":-0.65},{"market":"US","date":"2024-05-09","symbol":"RNA","fiscalQuarterEnding":"2024/03","expectedEps":-0.81,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-0.79},{"market":"US","date":"2024-02-28","symbol":"RNA","fiscalQuarterEnding":"2023/12","expectedEps":-0.54,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1709096400000,"reportTimeType":"post","actualEps":-0.79}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RNA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RNA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1538,"buy":0.8462,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8462,"analysts":13,"updateTime":1742270400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RNA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RNA","date":"2025-04-17","current":-9.607973,"percent":0.550628,"low":-41.796609,"twenty":-20.515463,"median":-11.126407,"eighty":-5.018968,"high":-1.864956,"avg":-13.167151,"sd":9.278278,"marketCap":3096668873},"quantilePoints":[{"date":"2020-06-12","current":-35.638406,"twenty":-29.775182,"median":-20.980345,"eighty":-20.980345,"marketCap":1007497743},{"date":"2020-06-19","current":-39.899176,"twenty":-39.116319,"median":-35.96886,"eighty":-26.843569,"marketCap":1127949695},{"date":"2020-06-26","current":-35.321452,"twenty":-39.755873,"median":-37.152541,"eighty":-35.448234,"marketCap":998537442},{"date":"2020-07-02","current":-35.653171,"twenty":-39.328619,"median":-36.138594,"eighty":-35.384843,"marketCap":1007915142},{"date":"2020-07-10","current":-35.746052,"twenty":-38.41042,"median":-36.382953,"eighty":-35.641359,"marketCap":1010540898},{"date":"2020-07-17","current":-34.352832,"twenty":-38.00705,"median":-36.138594,"eighty":-35.045462,"marketCap":971154560},{"date":"2020-07-24","current":-31.486779,"twenty":-37.457723,"median":-35.838933,"eighty":-32.192677,"marketCap":890131236},{"date":"2020-07-31","current":-37.404648,"twenty":-37.478953,"median":-36.117578,"eighty":-33.328484,"marketCap":1057429395},{"date":"2020-08-07","current":-38.121161,"twenty":-37.815979,"median":-36.147989,"eighty":-33.816774,"marketCap":1077685226},{"date":"2020-08-14","current":-32.261103,"twenty":-37.539989,"median":-35.87874,"eighty":-32.619559,"marketCap":1087521766},{"date":"2020-08-21","current":-33.897535,"twenty":-37.478953,"median":-35.772589,"eighty":-32.619559,"marketCap":1142685913},{"date":"2020-08-28","current":-31.749022,"twenty":-37.383418,"median":-35.638406,"eighty":-31.8314,"marketCap":1070259516},{"date":"2020-09-04","current":-31.949401,"twenty":-37.295844,"median":-35.095883,"eighty":-31.869249,"marketCap":1077014309},{"date":"2020-09-11","current":-37.281723,"twenty":-37.285229,"median":-35.268377,"eighty":-31.949401,"marketCap":1256766872},{"date":"2020-09-18","current":-38.194563,"twenty":-37.497529,"median":-35.653171,"eighty":-32.060723,"marketCap":1287538709},{"date":"2020-09-25","current":-32.45035,"twenty":-37.497529,"median":-35.645789,"eighty":-32.160913,"marketCap":1093901293},{"date":"2020-10-02","current":-31.860343,"twenty":-37.404648,"median":-35.215302,"eighty":-31.949401,"marketCap":1074012179},{"date":"2020-10-09","current":-30.802785,"twenty":-37.298498,"median":-34.503678,"eighty":-31.871476,"marketCap":1038361879},{"date":"2020-10-16","current":-31.726757,"twenty":-37.285229,"median":-33.897535,"eighty":-31.826947,"marketCap":1069508983},{"date":"2020-10-23","current":-31.125619,"twenty":-37.281723,"median":-33.665444,"eighty":-31.749022,"marketCap":1049244602},{"date":"2020-10-30","current":-27.529919,"twenty":-37.16581,"median":-33.313095,"eighty":-31.613224,"marketCap":928033584},{"date":"2020-11-06","current":-31.147883,"twenty":-37.152541,"median":-33.245062,"eighty":-31.420435,"marketCap":1049995135},{"date":"2020-11-13","current":-28.475809,"twenty":-37.148136,"median":-33.185075,"eighty":-31.147883,"marketCap":1095777625},{"date":"2020-11-20","current":-28.924401,"twenty":-37.112735,"median":-32.711956,"eighty":-30.969768,"marketCap":1113039875},{"date":"2020-11-27","current":-29.967864,"twenty":-36.97474,"median":-32.628465,"eighty":-30.631349,"marketCap":1153193370},{"date":"2020-12-04","current":-31.71347,"twenty":-36.937348,"median":-32.283367,"eighty":-30.353044,"marketCap":1220366040},{"date":"2020-12-11","current":-31.37215,"twenty":-36.722887,"median":-32.366858,"eighty":-30.408705,"marketCap":1207231719},{"date":"2020-12-18","current":-28.007714,"twenty":-36.620708,"median":-32.261103,"eighty":-30.184146,"marketCap":1077764842},{"date":"2020-12-24","current":-28.778121,"twenty":-36.497064,"median":-32.160913,"eighty":-30.079555,"marketCap":1107410880},{"date":"2020-12-31","current":-24.887077,"twenty":-36.316609,"median":-32.105252,"eighty":-29.407768,"marketCap":957679623},{"date":"2021-01-08","current":-27.451851,"twenty":-36.149868,"median":-32.005062,"eighty":-29.207279,"marketCap":1056374662},{"date":"2021-01-15","current":-25.803764,"twenty":-36.130188,"median":-31.860343,"eighty":-29.125292,"marketCap":992954656},{"date":"2021-01-22","current":-25.238149,"twenty":-36.089914,"median":-31.826947,"eighty":-28.936103,"marketCap":971189210},{"date":"2021-01-29","current":-22.312552,"twenty":-35.97035,"median":-31.754588,"eighty":-28.475809,"marketCap":858609317},{"date":"2021-02-05","current":-21.883465,"twenty":-35.92353,"median":-31.737889,"eighty":-28.025268,"marketCap":842097599},{"date":"2021-02-12","current":-21.727433,"twenty":-35.862817,"median":-31.708982,"eighty":-27.465504,"marketCap":836093338},{"date":"2021-02-19","current":-25.228397,"twenty":-35.799127,"median":-31.653595,"eighty":-26.778963,"marketCap":970813943},{"date":"2021-02-26","current":-23.531551,"twenty":-35.746052,"median":-31.486779,"eighty":-26.086572,"marketCap":905517606},{"date":"2021-03-05","current":-22.390568,"twenty":-35.653171,"median":-31.396293,"eighty":-25.940292,"marketCap":861611447},{"date":"2021-03-12","current":-25.004101,"twenty":-35.638406,"median":-31.225808,"eighty":-25.238149,"marketCap":962182818},{"date":"2021-03-19","current":-21.412757,"twenty":-35.321452,"median":-31.064391,"eighty":-25.004101,"marketCap":949762842},{"date":"2021-03-26","current":-17.828429,"twenty":-35.215302,"median":-30.969768,"eighty":-24.887077,"marketCap":790779984},{"date":"2021-04-01","current":-18.989311,"twenty":-35.024232,"median":-30.680331,"eighty":-24.762252,"marketCap":842270886},{"date":"2021-04-09","current":-18.72663,"twenty":-34.718913,"median":-30.446554,"eighty":-23.687583,"marketCap":830619660},{"date":"2021-04-16","current":-17.582695,"twenty":-34.413171,"median":-30.201646,"eighty":-23.329342,"marketCap":779880450},{"date":"2021-04-23","current":-19.048626,"twenty":-34.331602,"median":-30.09464,"eighty":-22.642588,"marketCap":844901808},{"date":"2021-04-30","current":-19.878228,"twenty":-34.264448,"median":-29.967864,"eighty":-22.388618,"marketCap":881698811},{"date":"2021-05-07","current":-18.504392,"twenty":-33.967825,"median":-29.319357,"eighty":-21.984885,"marketCap":820762289},{"date":"2021-05-14","current":-12.366031,"twenty":-33.808477,"median":-29.222013,"eighty":-21.780094,"marketCap":768103629},{"date":"2021-05-21","current":-13.322854,"twenty":-33.708758,"median":-29.156835,"eighty":-21.678673,"marketCap":827535742},{"date":"2021-05-28","current":-14.37657,"twenty":-33.651075,"median":-29.109689,"eighty":-21.248369,"marketCap":892986296},{"date":"2021-06-04","current":-13.528752,"twenty":-33.48787,"median":-28.982913,"eighty":-20.919439,"marketCap":840324930},{"date":"2021-06-11","current":-15.533236,"twenty":-33.342039,"median":-28.773245,"eighty":-20.304412,"marketCap":964831444},{"date":"2021-06-18","current":-16.235714,"twenty":-33.276359,"median":-28.475809,"eighty":-19.944808,"marketCap":1008465147},{"date":"2021-06-25","current":-17.719396,"twenty":-33.251868,"median":-28.20763,"eighty":-18.985306,"marketCap":1100622536},{"date":"2021-07-02","current":-14.3039,"twenty":-33.243701,"median":-27.69565,"eighty":-18.607999,"marketCap":888472464},{"date":"2021-07-09","current":-15.266779,"twenty":-33.225889,"median":-27.520114,"eighty":-18.486902,"marketCap":948280729},{"date":"2021-07-16","current":-13.777042,"twenty":-33.198433,"median":-27.183671,"eighty":-17.913165,"marketCap":855747187},{"date":"2021-07-23","current":-13.316798,"twenty":-33.073753,"median":-26.730203,"eighty":-17.637375,"marketCap":827159589},{"date":"2021-07-30","current":-11.693832,"twenty":-32.854637,"median":-26.218224,"eighty":-17.10309,"marketCap":726350689},{"date":"2021-08-06","current":-14.746344,"twenty":-32.752871,"median":-26.067068,"eighty":-16.259938,"marketCap":915954440},{"date":"2021-08-13","current":-11.436404,"twenty":-32.71307,"median":-25.872028,"eighty":-15.828761,"marketCap":891021641},{"date":"2021-08-20","current":-11.81156,"twenty":-32.688579,"median":-25.374677,"eighty":-15.39153,"marketCap":920250439},{"date":"2021-08-27","current":-11.881902,"twenty":-32.635144,"median":-25.223521,"eighty":-15.121439,"marketCap":925730839},{"date":"2021-09-03","current":-11.278135,"twenty":-32.554492,"median":-25.004101,"eighty":-14.763154,"marketCap":878690742},{"date":"2021-09-10","current":-13.224258,"twenty":-32.484973,"median":-24.974845,"eighty":-14.543711,"marketCap":1030315132},{"date":"2021-09-17","current":-14.044912,"twenty":-32.416953,"median":-24.862697,"eighty":-14.441383,"marketCap":1094253128},{"date":"2021-09-24","current":-13.734236,"twenty":-32.283367,"median":-24.779805,"eighty":-14.366881,"marketCap":1070048029},{"date":"2021-10-01","current":-13.611137,"twenty":-32.278914,"median":-24.024026,"eighty":-14.14795,"marketCap":1060457330},{"date":"2021-10-08","current":-13.441145,"twenty":-32.243291,"median":-23.531551,"eighty":-14.069443,"marketCap":1047213031},{"date":"2021-10-15","current":-12.614629,"twenty":-32.169819,"median":-23.441741,"eighty":-13.946434,"marketCap":982818335},{"date":"2021-10-22","current":-13.001509,"twenty":-32.160913,"median":-22.956183,"eighty":-13.742797,"marketCap":1012960533},{"date":"2021-10-29","current":-13.189087,"twenty":-32.149781,"median":-22.581778,"eighty":-13.630951,"marketCap":1027574932},{"date":"2021-11-05","current":-15.299341,"twenty":-32.09711,"median":-22.410072,"eighty":-13.655687,"marketCap":1191986921},{"date":"2021-11-12","current":-12.166812,"twenty":-32.063778,"median":-22.346684,"eighty":-13.593676,"marketCap":1164923541},{"date":"2021-11-19","current":-13.7195,"twenty":-32.038459,"median":-22.01024,"eighty":-13.566299,"marketCap":1313587294},{"date":"2021-11-26","current":-11.863131,"twenty":-31.949401,"median":-21.834705,"eighty":-13.499763,"marketCap":1135847350},{"date":"2021-12-03","current":-11.363528,"twenty":-31.871476,"median":-21.771317,"eighty":-13.400112,"marketCap":1088012325},{"date":"2021-12-10","current":-11.936602,"twenty":-31.860343,"median":-21.688425,"eighty":-13.322854,"marketCap":1142881912},{"date":"2021-12-17","current":-11.363528,"twenty":-31.849211,"median":-21.545715,"eighty":-13.25624,"marketCap":1088012325},{"date":"2021-12-23","current":-12.543963,"twenty":-31.8314,"median":-21.349205,"eighty":-13.175019,"marketCap":1201034295},{"date":"2021-12-31","current":-11.642718,"twenty":-31.820188,"median":-20.980345,"eighty":-13.050829,"marketCap":1114743662},{"date":"2022-01-07","current":-9.389605,"twenty":-31.771823,"median":-20.760217,"eighty":-12.953442,"marketCap":899017081},{"date":"2022-01-14","current":-8.733263,"twenty":-31.751248,"median":-20.311191,"eighty":-12.90702,"marketCap":836174989},{"date":"2022-01-21","current":-6.965059,"twenty":-31.742342,"median":-20.064799,"eighty":-12.792452,"marketCap":666876520},{"date":"2022-01-28","current":-7.464662,"twenty":-31.737889,"median":-19.933711,"eighty":-12.673256,"marketCap":714711544},{"date":"2022-02-04","current":-7.969164,"twenty":-31.73121,"median":-19.0217,"eighty":-12.607595,"marketCap":763015540},{"date":"2022-02-11","current":-7.85161,"twenty":-31.718785,"median":-18.924175,"eighty":-12.532803,"marketCap":751760240},{"date":"2022-02-18","current":-7.312822,"twenty":-31.708084,"median":-18.658841,"eighty":-12.451927,"marketCap":700173449},{"date":"2022-02-25","current":-8.013246,"twenty":-31.700282,"median":-18.504392,"eighty":-12.34642,"marketCap":767236277},{"date":"2022-03-04","current":-6.42211,"twenty":-31.661669,"median":-18.41632,"eighty":-12.182486,"marketCap":757866723},{"date":"2022-03-11","current":-7.093861,"twenty":-31.575306,"median":-18.040269,"eighty":-12.09334,"marketCap":837139487},{"date":"2022-03-18","current":-7.478298,"twenty":-31.50577,"median":-17.752167,"eighty":-11.945203,"marketCap":882506430},{"date":"2022-03-25","current":-7.004834,"twenty":-31.476164,"median":-17.582695,"eighty":-11.873443,"marketCap":826633458},{"date":"2022-04-01","current":-8.097442,"twenty":-31.444319,"median":-17.294593,"eighty":-11.825906,"marketCap":955571086},{"date":"2022-04-08","current":-7.988182,"twenty":-31.401121,"median":-16.853967,"eighty":-11.719268,"marketCap":942677323},{"date":"2022-04-14","current":-7.373084,"twenty":-31.365146,"median":-16.296273,"eighty":-11.643698,"marketCap":870090214},{"date":"2022-04-22","current":-6.745845,"twenty":-31.314866,"median":-16.08129,"eighty":-11.54955,"marketCap":796070465},{"date":"2022-04-29","current":-6.030185,"twenty":-31.210223,"median":-15.799693,"eighty":-11.378103,"marketCap":711616090},{"date":"2022-05-06","current":-5.726567,"twenty":-31.14343,"median":-15.63013,"eighty":-11.319167,"marketCap":675786469},{"date":"2022-05-13","current":-5.018968,"twenty":-31.101128,"median":-15.299341,"eighty":-11.132571,"marketCap":644435550},{"date":"2022-05-20","current":-5.018968,"twenty":-30.999044,"median":-15.266779,"eighty":-10.917803,"marketCap":644435550},{"date":"2022-05-27","current":-5.670078,"twenty":-30.980006,"median":-15.085104,"eighty":-10.201035,"marketCap":728038000},{"date":"2022-06-03","current":-5.080979,"twenty":-30.969768,"median":-14.994266,"eighty":-9.134905,"marketCap":652397688},{"date":"2022-06-10","current":-4.918202,"twenty":-30.802785,"median":-14.767356,"eighty":-8.321825,"marketCap":631497076},{"date":"2022-06-17","current":-4.976336,"twenty":-30.680331,"median":-14.582469,"eighty":-8.263048,"marketCap":638961580},{"date":"2022-06-24","current":-5.511176,"twenty":-30.671425,"median":-14.503743,"eighty":-8.133739,"marketCap":707635021},{"date":"2022-07-01","current":-5.991757,"twenty":-30.517801,"median":-14.446601,"eighty":-8.061832,"marketCap":769341591},{"date":"2022-07-08","current":-6.615737,"twenty":-30.439875,"median":-14.434107,"eighty":-8.00322,"marketCap":849460606},{"date":"2022-07-15","current":-6.794017,"twenty":-30.3998,"median":-14.37657,"eighty":-7.922142,"marketCap":872351753},{"date":"2022-07-22","current":-6.418079,"twenty":-30.277345,"median":-14.265264,"eighty":-7.829079,"marketCap":824081291},{"date":"2022-07-29","current":-6.313436,"twenty":-30.149145,"median":-14.128281,"eighty":-7.661565,"marketCap":810645183},{"date":"2022-08-05","current":-7.359862,"twenty":-30.102442,"median":-14.079861,"eighty":-7.498145,"marketCap":945006263},{"date":"2022-08-12","current":-7.744765,"twenty":-30.09464,"median":-14.061667,"eighty":-7.476679,"marketCap":1144188352},{"date":"2022-08-19","current":-7.3884,"twenty":-30.072013,"median":-14.02967,"eighty":-7.470415,"marketCap":1091540050},{"date":"2022-08-26","current":-7.741237,"twenty":-30.00349,"median":-13.904228,"eighty":-7.470415,"marketCap":1143667082},{"date":"2022-09-02","current":-7.501308,"twenty":-29.680657,"median":-13.816405,"eighty":-7.464662,"marketCap":1108220700},{"date":"2022-09-09","current":-7.363701,"twenty":-29.434907,"median":-13.754752,"eighty":-7.442192,"marketCap":1087891157},{"date":"2022-09-16","current":-7.349588,"twenty":-29.326183,"median":-13.669756,"eighty":-7.391986,"marketCap":1085806076},{"date":"2022-09-23","current":-6.541592,"twenty":-29.285225,"median":-13.638908,"eighty":-7.361398,"marketCap":966435173},{"date":"2022-09-30","current":-5.761823,"twenty":-29.25994,"median":-13.589311,"eighty":-7.336663,"marketCap":851234432},{"date":"2022-10-07","current":-5.779465,"twenty":-29.212191,"median":-13.561735,"eighty":-7.29548,"marketCap":853840784},{"date":"2022-10-14","current":-5.79005,"twenty":-29.181854,"median":-13.499763,"eighty":-7.22525,"marketCap":855404595},{"date":"2022-10-21","current":-5.020866,"twenty":-29.157157,"median":-13.418819,"eighty":-7.180208,"marketCap":741767665},{"date":"2022-10-28","current":-5.130245,"twenty":-29.152611,"median":-13.388388,"eighty":-7.120264,"marketCap":757927045},{"date":"2022-11-04","current":-4.784465,"twenty":-29.133094,"median":-13.325882,"eighty":-7.077936,"marketCap":706842553},{"date":"2022-11-11","current":-4.987127,"twenty":-29.082383,"median":-13.286519,"eighty":-7.007322,"marketCap":808223767},{"date":"2022-11-18","current":-4.076405,"twenty":-29.01802,"median":-13.240249,"eighty":-6.959181,"marketCap":660630343},{"date":"2022-11-25","current":-4.210829,"twenty":-28.971211,"median":-13.206672,"eighty":-6.908542,"marketCap":682415350},{"date":"2022-12-02","current":-3.908375,"twenty":-28.895145,"median":-13.107021,"eighty":-6.819609,"marketCap":633399084},{"date":"2022-12-09","current":-3.666412,"twenty":-28.776171,"median":-13.032334,"eighty":-6.759911,"marketCap":594186071},{"date":"2022-12-16","current":-7.552337,"twenty":-28.709857,"median":-12.972199,"eighty":-6.729659,"marketCap":1223946832},{"date":"2022-12-23","current":-8.569155,"twenty":-28.475809,"median":-12.939832,"eighty":-6.746629,"marketCap":1388734462},{"date":"2022-12-30","current":-9.098065,"twenty":-28.475809,"median":-12.916512,"eighty":-6.749766,"marketCap":1474450608},{"date":"2023-01-06","current":-8.130447,"twenty":-28.468007,"median":-12.870801,"eighty":-6.757262,"marketCap":1317636573},{"date":"2023-01-13","current":-9.286668,"twenty":-28.349034,"median":-12.790483,"eighty":-6.762237,"marketCap":1505016056},{"date":"2023-01-20","current":-9.212867,"twenty":-28.1852,"median":-12.679109,"eighty":-6.781615,"marketCap":1493055663},{"date":"2023-01-27","current":-9.622875,"twenty":-28.042821,"median":-12.668823,"eighty":-6.805644,"marketCap":1559502288},{"date":"2023-02-03","current":-9.90988,"twenty":-27.820476,"median":-12.614629,"eighty":-6.815441,"marketCap":1606014926},{"date":"2023-02-10","current":-9.319469,"twenty":-27.596211,"median":-12.557946,"eighty":-6.825218,"marketCap":1510331786},{"date":"2023-02-17","current":-10.516691,"twenty":-27.524036,"median":-12.524371,"eighty":-6.862225,"marketCap":1704355931},{"date":"2023-02-24","current":-9.335869,"twenty":-27.492809,"median":-12.493203,"eighty":-6.889742,"marketCap":1512989651},{"date":"2023-03-03","current":-10.035487,"twenty":-27.440149,"median":-12.425244,"eighty":-6.901778,"marketCap":1746124614},{"date":"2023-03-10","current":-8.354767,"twenty":-27.231456,"median":-12.333346,"eighty":-6.912071,"marketCap":1453687685},{"date":"2023-03-17","current":-8.346628,"twenty":-26.878433,"median":-12.20808,"eighty":-6.923154,"marketCap":1452271526},{"date":"2023-03-24","current":-8.15129,"twenty":-26.759459,"median":-12.160132,"eighty":-6.936445,"marketCap":1418283699},{"date":"2023-03-31","current":-6.246745,"twenty":-26.718501,"median":-12.09334,"eighty":-6.923154,"marketCap":1086902385},{"date":"2023-04-06","current":-5.514228,"twenty":-26.630733,"median":-12.022319,"eighty":-6.88645,"marketCap":959448034},{"date":"2023-04-14","current":-6.210119,"twenty":-26.297215,"median":-11.936602,"eighty":-6.814077,"marketCap":1080529667},{"date":"2023-04-21","current":-6.409527,"twenty":-26.086572,"median":-11.881733,"eighty":-6.75164,"marketCap":1115225574},{"date":"2023-04-28","current":-5.921182,"twenty":-26.082671,"median":-11.863131,"eighty":-6.746629,"marketCap":1030256007},{"date":"2023-05-05","current":-4.55822,"twenty":-26.057316,"median":-11.826396,"eighty":-6.654268,"marketCap":793107504},{"date":"2023-05-12","current":-4.123772,"twenty":-26.002705,"median":-11.770068,"eighty":-6.61586,"marketCap":792399372},{"date":"2023-05-19","current":-3.939845,"twenty":-25.912986,"median":-11.705944,"eighty":-6.582075,"marketCap":757056927},{"date":"2023-05-26","current":-4.028298,"twenty":-25.768657,"median":-11.642718,"eighty":-6.532696,"marketCap":774053528},{"date":"2023-06-02","current":-4.006185,"twenty":-25.628229,"median":-11.606396,"eighty":-6.507219,"marketCap":769804377},{"date":"2023-06-09","current":-4.38211,"twenty":-25.425387,"median":-11.536054,"eighty":-6.447533,"marketCap":842039931},{"date":"2023-06-16","current":-4.599557,"twenty":-25.265455,"median":-11.451058,"eighty":-6.417304,"marketCap":883823241},{"date":"2023-06-23","current":-4.297342,"twenty":-25.232298,"median":-11.363528,"eighty":-6.355731,"marketCap":825751522},{"date":"2023-06-30","current":-4.087266,"twenty":-25.224496,"median":-11.343275,"eighty":-6.280747,"marketCap":785384595},{"date":"2023-07-07","current":-3.973015,"twenty":-25.19329,"median":-11.29572,"eighty":-6.217444,"marketCap":763430652},{"date":"2023-07-14","current":-4.083581,"twenty":-25.074315,"median":-11.149175,"eighty":-6.034901,"marketCap":784676403},{"date":"2023-07-21","current":-3.718712,"twenty":-25.0002,"median":-11.00556,"eighty":-5.918732,"marketCap":714565425},{"date":"2023-07-28","current":-3.353844,"twenty":-24.982647,"median":-10.912905,"eighty":-5.893783,"marketCap":644454447},{"date":"2023-08-04","current":-3.449668,"twenty":-24.963143,"median":-10.690816,"eighty":-5.812632,"marketCap":662867431},{"date":"2023-08-11","current":-3.431213,"twenty":-24.910482,"median":-10.45519,"eighty":-5.790085,"marketCap":663902014},{"date":"2023-08-18","current":-3.15932,"twenty":-24.877325,"median":-10.098356,"eighty":-5.73622,"marketCap":611293707},{"date":"2023-08-25","current":-3.036777,"twenty":-24.830515,"median":-9.963181,"eighty":-5.694292,"marketCap":587582921},{"date":"2023-09-01","current":-2.895086,"twenty":-24.795408,"median":-9.92423,"eighty":-5.645386,"marketCap":560167324},{"date":"2023-09-08","current":-2.657658,"twenty":-24.779805,"median":-9.89937,"eighty":-5.620688,"marketCap":514227676},{"date":"2023-09-15","current":-2.79169,"twenty":-24.692038,"median":-9.799178,"eighty":-5.507781,"marketCap":540161349},{"date":"2023-09-22","current":-2.665317,"twenty":-24.321462,"median":-9.686426,"eighty":-5.398782,"marketCap":515709600},{"date":"2023-09-29","current":-2.512138,"twenty":-23.726591,"median":-9.659775,"eighty":-5.29414,"marketCap":486071117},{"date":"2023-10-06","current":-2.385765,"twenty":-23.726591,"median":-9.633125,"eighty":-5.197248,"marketCap":461619369},{"date":"2023-10-13","current":-2.339812,"twenty":-23.531551,"median":-9.508072,"eighty":-5.09849,"marketCap":452727824},{"date":"2023-10-20","current":-2.113872,"twenty":-23.531551,"median":-9.377088,"eighty":-5.020866,"marketCap":409011062},{"date":"2023-10-27","current":-2.021965,"twenty":-23.52765,"median":-9.35022,"eighty":-5.018968,"marketCap":391227972},{"date":"2023-11-03","current":-1.937716,"twenty":-23.457752,"median":-9.319469,"eighty":-4.995462,"marketCap":374926807},{"date":"2023-11-10","current":-2.007807,"twenty":-23.297002,"median":-9.252089,"eighty":-4.97662,"marketCap":406074871},{"date":"2023-11-17","current":-2.172681,"twenty":-23.102463,"median":-9.208767,"eighty":-4.944556,"marketCap":439420436},{"date":"2023-11-24","current":-2.293589,"twenty":-22.944481,"median":-9.098065,"eighty":-4.9058,"marketCap":463873850},{"date":"2023-12-01","current":-2.861491,"twenty":-22.854762,"median":-9.062046,"eighty":-4.817675,"marketCap":578730793},{"date":"2023-12-08","current":-2.949424,"twenty":-22.642588,"median":-9.020164,"eighty":-4.736046,"marketCap":596515094},{"date":"2023-12-15","current":-2.942096,"twenty":-22.478734,"median":-8.888495,"eighty":-4.694967,"marketCap":595033069},{"date":"2023-12-22","current":-3.326804,"twenty":-22.459579,"median":-8.782359,"eighty":-4.625203,"marketCap":672839386},{"date":"2023-12-29","current":-3.418401,"twenty":-22.422449,"median":-8.716971,"eighty":-4.575798,"marketCap":691364699},{"date":"2024-01-05","current":-3.605259,"twenty":-22.40227,"median":-8.619287,"eighty":-4.546011,"marketCap":729156339},{"date":"2024-01-12","current":-4.121866,"twenty":-22.386667,"median":-8.480923,"eighty":-4.474248,"marketCap":833639107},{"date":"2024-01-19","current":-3.821428,"twenty":-22.367163,"median":-8.410527,"eighty":-4.373264,"marketCap":772876079},{"date":"2024-01-26","current":-4.11118,"twenty":-22.291896,"median":-8.346628,"eighty":-4.316264,"marketCap":831478023},{"date":"2024-02-02","current":-4.766927,"twenty":-22.169467,"median":-8.324274,"eighty":-4.333222,"marketCap":964101547},{"date":"2024-02-09","current":-4.912213,"twenty":-21.984885,"median":-8.302651,"eighty":-4.337146,"marketCap":993485202},{"date":"2024-02-16","current":-5.312729,"twenty":-21.873713,"median":-8.279699,"eighty":-4.353363,"marketCap":1074488792},{"date":"2024-02-23","current":-5.709318,"twenty":-21.834705,"median":-8.254149,"eighty":-4.371053,"marketCap":1154698229},{"date":"2024-03-01","current":-6.884704,"twenty":-21.815201,"median":-8.220472,"eighty":-4.38211,"marketCap":1461071871},{"date":"2024-03-08","current":-7.531791,"twenty":-21.785945,"median":-8.189978,"eighty":-4.452135,"marketCap":1598396659},{"date":"2024-03-15","current":-9.017834,"twenty":-21.756689,"median":-8.204249,"eighty":-4.466877,"marketCap":1913764632},{"date":"2024-03-22","current":-9.066741,"twenty":-21.727433,"median":-8.229515,"eighty":-4.485305,"marketCap":1924143831},{"date":"2024-03-28","current":-9.281183,"twenty":-21.696227,"median":-8.254149,"eighty":-4.491202,"marketCap":1969652627},{"date":"2024-04-05","current":-10.661495,"twenty":-21.680623,"median":-8.292436,"eighty":-4.519064,"marketCap":2262582364},{"date":"2024-04-12","current":-11.408564,"twenty":-21.678673,"median":-8.304891,"eighty":-4.535429,"marketCap":2421125493},{"date":"2024-04-19","current":-10.368967,"twenty":-21.46594,"median":-8.326723,"eighty":-4.55415,"marketCap":2200502223},{"date":"2024-04-26","current":-10.7245,"twenty":-21.412757,"median":-8.350698,"eighty":-4.564979,"marketCap":2275953471},{"date":"2024-05-03","current":-11.526166,"twenty":-21.311074,"median":-8.417453,"eighty":-4.569664,"marketCap":2446082844},{"date":"2024-05-10","current":-12.211067,"twenty":-21.136518,"median":-8.528949,"eighty":-4.570559,"marketCap":2591432567},{"date":"2024-05-17","current":-12.011,"twenty":-21.004123,"median":-8.619287,"eighty":-4.575834,"marketCap":2746687402},{"date":"2024-05-24","current":-11.488237,"twenty":-20.980345,"median":-8.728825,"eighty":-4.595074,"marketCap":2627141467},{"date":"2024-05-31","current":-11.316771,"twenty":-20.888986,"median":-8.784409,"eighty":-4.609363,"marketCap":2587930400},{"date":"2024-06-07","current":-10.890196,"twenty":-20.746644,"median":-8.909462,"eighty":-4.626414,"marketCap":2490380917},{"date":"2024-06-14","current":-16.711683,"twenty":-20.65513,"median":-8.938982,"eighty":-4.645017,"marketCap":3821644450},{"date":"2024-06-21","current":-17.463994,"twenty":-20.541673,"median":-9.002785,"eighty":-4.663959,"marketCap":3993683592},{"date":"2024-06-28","current":-18.824523,"twenty":-20.426432,"median":-9.017834,"eighty":-4.66706,"marketCap":4304810763},{"date":"2024-07-05","current":-17.278256,"twenty":-20.304412,"median":-9.028364,"eighty":-4.67213,"marketCap":3951208893},{"date":"2024-07-12","current":-20.575102,"twenty":-20.304412,"median":-9.060735,"eighty":-4.682062,"marketCap":4705134803},{"date":"2024-07-15","current":-20.80263,"twenty":-20.416755,"median":-9.066741,"eighty":-4.685549,"marketCap":4757166310},{"date":"2024-08-02","current":-20.695831,"twenty":-20.57994,"median":-9.068053,"eighty":-4.689037,"marketCap":4732743358},{"date":"2024-08-09","current":-19.442101,"twenty":-20.389364,"median":-9.098065,"eighty":-4.702292,"marketCap":4446039138},{"date":"2024-08-16","current":-21.104668,"twenty":-20.45155,"median":-9.161017,"eighty":-4.704816,"marketCap":5327852349},{"date":"2024-08-23","current":-19.882184,"twenty":-20.693049,"median":-9.212867,"eighty":-4.711267,"marketCap":5019237468},{"date":"2024-08-30","current":-19.782437,"twenty":-20.617905,"median":-9.283926,"eighty":-4.724704,"marketCap":4994056368},{"date":"2024-09-06","current":-18.910228,"twenty":-20.584778,"median":-9.305118,"eighty":-4.728041,"marketCap":4773868141},{"date":"2024-09-13","current":-19.165395,"twenty":-20.528184,"median":-9.335869,"eighty":-4.751474,"marketCap":4838284910},{"date":"2024-09-20","current":-21.178899,"twenty":-20.584778,"median":-9.377088,"eighty":-4.766927,"marketCap":5346591773},{"date":"2024-09-27","current":-19.564385,"twenty":-20.614011,"median":-9.508072,"eighty":-4.767001,"marketCap":4939009311},{"date":"2024-10-04","current":-21.828416,"twenty":-20.69977,"median":-9.611919,"eighty":-4.777499,"marketCap":5510561728},{"date":"2024-10-11","current":-20.515463,"twenty":-20.808388,"median":-9.644811,"eighty":-4.795146,"marketCap":5179108175},{"date":"2024-10-18","current":-22.510409,"twenty":-20.924108,"median":-9.672717,"eighty":-4.8043,"marketCap":5682730182},{"date":"2024-10-25","current":-20.946928,"twenty":-21.062913,"median":-9.717176,"eighty":-4.807671,"marketCap":5288031074},{"date":"2024-10-31","current":-20.051522,"twenty":-21.062913,"median":-9.811478,"eighty":-4.820452,"marketCap":5061986778},{"date":"2024-11-08","current":-19.838416,"twenty":-21.062913,"median":-9.907571,"eighty":-4.84349,"marketCap":5564437571},{"date":"2024-11-15","current":-21.255407,"twenty":-21.084706,"median":-9.93858,"eighty":-4.869368,"marketCap":5961886570},{"date":"2024-11-22","current":-18.103464,"twenty":-21.062913,"median":-9.999334,"eighty":-4.898048,"marketCap":5077804531},{"date":"2024-11-29","current":-18.303385,"twenty":-21.046399,"median":-10.098356,"eighty":-4.902699,"marketCap":5133879910},{"date":"2024-12-06","current":-15.687401,"twenty":-20.980345,"median":-10.127184,"eighty":-4.904602,"marketCap":4400127610},{"date":"2024-12-13","current":-14.360267,"twenty":-20.973662,"median":-10.412078,"eighty":-4.913411,"marketCap":4027882541},{"date":"2024-12-20","current":-13.207532,"twenty":-20.943217,"median":-10.598489,"eighty":-4.922504,"marketCap":3704554292},{"date":"2024-12-27","current":-13.237308,"twenty":-20.928371,"median":-10.661495,"eighty":-4.939713,"marketCap":3712905945},{"date":"2025-01-03","current":-13.262829,"twenty":-20.920948,"median":-10.736574,"eighty":-4.941107,"marketCap":3720064504},{"date":"2025-01-10","current":-12.731125,"twenty":-20.899606,"median":-10.760504,"eighty":-4.946106,"marketCap":3570927857},{"date":"2025-01-17","current":-12.033529,"twenty":-20.875481,"median":-10.849125,"eighty":-4.95057,"marketCap":3375260577},{"date":"2025-01-24","current":-12.816198,"twenty":-20.852067,"median":-10.87291,"eighty":-4.952418,"marketCap":3594789721},{"date":"2025-01-31","current":-13.879606,"twenty":-20.823658,"median":-10.890196,"eighty":-4.960884,"marketCap":3893063013},{"date":"2025-02-07","current":-14.934507,"twenty":-20.811267,"median":-10.956919,"eighty":-4.973416,"marketCap":4188950119},{"date":"2025-02-14","current":-14.045498,"twenty":-20.799109,"median":-11.007295,"eighty":-4.97662,"marketCap":3939593647},{"date":"2025-02-21","current":-13.83707,"twenty":-20.776198,"median":-11.084534,"eighty":-4.979061,"marketCap":3881132082},{"date":"2025-02-28","current":-10.764795,"twenty":-20.703709,"median":-11.126407,"eighty":-4.987294,"marketCap":3469514938},{"date":"2025-03-07","current":-11.319953,"twenty":-20.695136,"median":-11.124394,"eighty":-4.988898,"marketCap":3648443335},{"date":"2025-03-14","current":-11.983857,"twenty":-20.689452,"median":-11.128498,"eighty":-4.99405,"marketCap":3862421231},{"date":"2025-03-21","current":-11.498983,"twenty":-20.669492,"median":-11.149175,"eighty":-5.000402,"marketCap":3706145239},{"date":"2025-03-28","current":-12.144239,"twenty":-20.628729,"median":-11.183518,"eighty":-5.004574,"marketCap":3914112520},{"date":"2025-04-04","current":-10.480747,"twenty":-20.594455,"median":-11.15204,"eighty":-5.011771,"marketCap":3377965658},{"date":"2025-04-11","current":-8.992555,"twenty":-20.563174,"median":-11.12911,"eighty":-5.018968,"marketCap":2898318577},{"date":"2025-04-17","current":-9.607973,"twenty":-20.515463,"median":-11.126407,"eighty":-5.018968,"marketCap":3096668873}],"updateTime":1745231483298}}}